Related Experiment Video
Updated: Sep 8, 2026

Viral Tracing of Genetically Defined Neural Circuitry
Published on: October 17, 2012
Ribavirin inhibits West Nile virus replication and cytopathic effect in neural cells
I Jordan1, T Briese, N Fischer
1Emerging Diseases Laboratory, Departments of Microbiology and Molecular Genetics, Neurology, and Anatomy and Neurobiology, University of California, Irvine, CA 92697-4292, USA.
Abstract:
West Nile virus (WNV) is an emerging mosquito-borne pathogen that was reported for the first time in the Western hemisphere in August 1999, when an encephalitis outbreak in New York City resulted in 62 clinical cases and 7 deaths. WNV, for which no antiviral therapy has been described, was recently recovered from a pool of mosquitoes collected in New York City. In anticipation of the recurrence of WNV during the summer of 2000, an analysis was made of the efficacy of the nucleoside analogue ribavirin, a broad-spectrum antiviral compound with activity against several RNA viruses, for treatment of WNV infection. High doses of ribavirin were found to inhibit WNV replication and cytopathogenicity in human neural cells in vitro.
More Related Videos
Related Concept Videos
Rabies
Arboviral Encephalitis
Inhibitors of Viral Protein Synthesis
Inhibitors Of Virion Release
Antiviral Nucleoside Inhibitors
Encephalitis ll: Pathophysiology

